01—Abstract
Summary
Summary of the 10-Q filed April 29, 2025. Cited figures are marked; the original filing is the authoritative source.
Tenet Healthcare Corporation's Form 10-Q for the quarter ended March 31, 2025 reports net operating revenues of $5.223 billiona for the three months ended March 31, 2025, down from $5.368 billion a year earlier, with the decline attributed mainly to the sale of hospitals in 2024 (the Divested Hospitals).
Net income was $622 millionb, versus $2.334 billion in the prior-year period, which included a $2.500 billion gain on sales, consolidation and deconsolidation of facilities. Net income available to Tenet common shareholders was $406 million, or $4.27 per diluted share, compared with $2.151 billion, or $21.38 per diluted share, a year earlier. Operating results shifted toward the Ambulatory Care segment, whose net operating revenues rose to $1.194 billion from $995 million, driven by newly acquired ASCs and higher net revenue per case.
Hospital Operations revenues fell to $4.029 billionc from $4.373 billion, primarily reflecting the sale of the Divested Hospitals, though the filing cites a more favorable payer mix, higher patient volume and acuity, and commercial rate increases. Net cash provided by operating activities was $815 million, compared with $586 million in the prior-year period. Balance sheet and capital return items: cash and cash equivalents were $2.999 billion at March 31, 2025, and long-term debt was $13.082 billion net of current portion.
Tenet repurchased $348 milliond of common stock in the quarter under a $1.500 billion program authorized in July 2024, leaving $1.028 billion available. The company stated it had no material changes to its risk factors from its 2024 Form 10-K.
02—Key points
Key Highlights
- Net operating revenues of $5.223 billion, down from $5.368 billion, with Hospital Operations declining to $4.029 billion and Ambulatory Care rising to $1.194 billion.
- Net income of $622 million, compared with $2.334 billion in the prior-year quarter, which included a $2.500 billion gain on facility sales, consolidation and deconsolidation.
- Diluted earnings per share of $4.27 to Tenet common shareholders, versus $21.38 a year earlier.
- Operating income of $943 million, compared with $3.285 billion in the prior-year period.
- Net cash provided by operating activities of $815 million, up from $586 million.
- Total admissions fell 11.9% to 120,090, mainly due to the sale of the Divested Hospitals; Ambulatory Care total consolidated cases rose 13.7% to 454,288.
- Repurchased $348 million of common stock; $1.028 billion remained available under the $1.500 billion program authorized in July 2024.
03—One dollar
04—Financials
Financial Highlights
Figures from 10-QQ1 FY2025filed April 29, 2025Financial Statements
Q1 FY2025 against Q1 FY2024
| Line item | Q1 FY2025Q1 FY2024 | Change |
|---|---|---|
| Revenue | $5.22B$5.37B | −2.7% |
| Operating Income | $943.00M$3.29B | −71.3% |
| Net Income | $406.00M$2.15B | −81.1% |
| EPS (Basic) | $4.31$21.60 | −80.0% |
| EPS (Diluted) | $4.27$21.38 | −80.0% |
| Shares Outstanding (Basic) | 94.24M99.58M | −5.4% |
| Shares Outstanding (Diluted) | 95.02M100.60M | −5.5% |
05—Questions
Frequently Asked Questions
Why did net income fall so sharply compared with the prior-year quarter?
The prior-year quarter included net gains on sales, consolidation and deconsolidation of facilities of $2.500 billion, mainly from the sale of the SC Hospitals, the Orange County and Los Angeles County hospitals, and the Central California hospitals. The 2025 quarter recorded a gain of only $22 million, so net income declined to $622 million from $2.334 billion.
How did the divestitures affect hospital revenues and volumes?
The filing attributes the 7.9% decline in Hospital Operations net operating revenues, to $4.029 billion, primarily to the sales of the Divested Hospitals in 2024. Total admissions fell 11.9%, and total surgeries fell 19.2%, for the same reason. Same-hospital net operating revenues rose 6.5%, to $4.009 billion.
What is driving growth in the Ambulatory Care segment?
Ambulatory Care net operating revenues rose 20.0%, to $1.194 billion, driven by a $114 million increase from acquisitions, net of facility closures, and an $85 million increase in same-facility net operating revenues reflecting higher net revenue per case. The company operated 387 consolidated facilities at the end of the period, up from 380.
How is the company returning capital and managing its debt?
Tenet repurchased $348 million of common stock in the quarter, leaving $1.028 billion available under the $1.500 billion program authorized in July 2024. Long-term debt, net of the current portion, was $13.082 billion, and the filing states that all long-term debt carries fixed rates except for borrowings under the Credit Agreement, of which none were outstanding at March 31, 2025.
What regulatory and policy risks does the filing highlight?
The filing notes that certain Affordable Care Act provisions are set to expire at the end of 2025 and could lead to a rise in uninsured patients or reduced enrollment, adversely affecting volumes and revenues if not extended. It also cites Medicaid disproportionate share hospital payment reductions scheduled to begin October 1, 2025, and CMS's April 2025 proposed IPPS rule, which would yield an average 3.4% increase in Medicare operating payments for proprietary hospitals in FFY 2026.
06—Continue